Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q1 2024 Earnings

15FebConfirmed

Q2 2023

Q3 2023

Q4 2023

Q1 2024

-10.87

-4.37

2.12

8.62

Details

Expected EPS

-6.265098

Actual EPS

-3.828671

Surprise EPS

2.44

Surprise Percent

+38.89%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -3.828671 per share for Q1 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.